GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » 3-Year ROIIC %

Dian Diagnostics Group Co (SZSE:300244) 3-Year ROIIC % : -18.35% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Dian Diagnostics Group Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -18.35%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Dian Diagnostics Group Co's 3-Year ROIIC % or its related term are showing as below:

SZSE:300244's 3-Year ROIIC % is ranked worse than
59.82% of 219 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.35 vs SZSE:300244: -18.35

Dian Diagnostics Group Co 3-Year ROIIC % Historical Data

The historical data trend for Dian Diagnostics Group Co's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co 3-Year ROIIC % Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.83 41.94 38.03 50.48 -18.35

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -18.35 -

Competitive Comparison of Dian Diagnostics Group Co's 3-Year ROIIC %

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's 3-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's 3-Year ROIIC % falls into.



Dian Diagnostics Group Co 3-Year ROIIC % Calculation

Dian Diagnostics Group Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 1081.461164 (Dec. 2023) - 1636.1468486 (Dec. 2020) )/( 11381.766 (Dec. 2023) - 8358.636 (Dec. 2020) )
=-554.6856846/3023.13
=-18.35%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Dian Diagnostics Group Co  (SZSE:300244) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Dian Diagnostics Group Co 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines